Screening patients with colorectal cancer for lynch syndrome: What are we waiting for?

Journal of Clinical Oncology

Volumn 30, Issue 10, 2012, Pages 1024-1027

  Kastrinos, Fay ^a,b,c,d   Syngal, Sapna ^a,b,c,d  

^a NewYork Presbyterian Hospital   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH6;

CANCER SCREENING; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COLORECTAL CANCER; DNA METHYLATION; EDITORIAL; GENE MUTATION; GENETIC SCREENING; HEALTH CARE UTILIZATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; UNITED STATES;

COLORECTAL NEOPLASMS; FEMALE; GENETIC TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; STANDARD OF CARE;

EID: 84863903548     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.7171     Document Type: Editorial

References (20)

1. Ladabaum U, Wang G, Terdiman J, at al: Strategies to identify the Lynch syndrome among patients with colorectal cancer: A cost-effectiveness analysis. Ann Intern Med 155:69-79, 2011
2. Bessa X, Ballesté B, Andreu M, et al: A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. Clin Gastroenterol Hepatol 6:206-214, 2008
3. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35-41, 2009
4. Hampel H, Frankel WL, Martin E, et al: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851-1860, 2005
5. Hampel H: Point: Justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer. J Natl Compr Canc Netw 8:597-601, 2010
6. Hall MJ: Counterpoint: Implementing population genetic screening for Lynch syndrome among newly diagnosed colorectal cancer patients - Will the ends justify the means? J Natl Compr Canc Netw 8:606-611, 2010
7. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al: A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758-1762, 1997
8. Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004 (Pubitemid 38256271)
9. Hampel H, Frankel WL, Martin E, et al: Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26:5783-5788, 2008
10. Salovaara R, Loukola A, Kristo P, et al: Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18:2193-2200, 2000 (Pubitemid 30350210)
11. de la Chapelle A, Palomaki G, Hampel H: Identifying Lynch syndrome. Int J Cancer 125:1492-1493, 2009
12. Beamer LC, Grant ML, Espendschied CR, et al: Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol 30:1058-1063, 2012
13. Balmaña J, Stockwell DH, Steyerberg EW, et al: Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 296:1469-1478, 2006 (Pubitemid 44465511)
14. Barnetson RA, Tenesa A, Farrington SM, et al: Identification and survival of carriers of mutations in DNA mismatch repair genes in colon cancers. N Engl J Med 354:2751-2763, 2006 (Pubitemid 43974193)
15. Chen S, Wang W, Lee S, et al: Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296:1479-1487, 2006 (Pubitemid 44465512)
16. Balmaña J, Balaguer F, Castellví-Bel S, et al: Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet 45:557-563, 2008
17. Green RC, Parfrey PS, Woods MO, et al: Prediction of Lynch syndrome in consecutive patients with colorectal cancer. J Natl Cancer Inst 101:331-340, 2009
18. Monzon JG, Cremin C, Armstrong L, et al: Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer. Int J Cancer 126:930-939, 2010
19. Boland CR, Shike M: Report from the Jerusalem Workshop on Lynch Syndrome-Hereditary nonpolyposis colorectal cancer. Gastroenterology 138: 2197-2201, 2010
20. Lindor NM, Rabe K, Petersen GM, et al: Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X. JAMA 293:1979-1985, 2005 (Pubitemid 40570891)